table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Gene Therapy Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Gene Therapy Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Gene Therapy Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Gene Therapy Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Gene Therapy Drugs Industry Impact
Chapter 2 Global Gene Therapy Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Gene Therapy Drugs (Volume and Value) by Type
2.1.1 Global Gene Therapy Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Gene Therapy Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Gene Therapy Drugs (Volume and Value) by Application
2.2.1 Global Gene Therapy Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Gene Therapy Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Gene Therapy Drugs (Volume and Value) by Regions
2.3.1 Global Gene Therapy Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Gene Therapy Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Gene Therapy Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Gene Therapy Drugs Consumption by Regions (2016-2021)
4.2 North America Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Gene Therapy Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Gene Therapy Drugs Market Analysis
5.1 North America Gene Therapy Drugs Consumption and Value Analysis
5.1.1 North America Gene Therapy Drugs Market Under COVID-19
5.2 North America Gene Therapy Drugs Consumption Volume by Types
5.3 North America Gene Therapy Drugs Consumption Structure by Application
5.4 North America Gene Therapy Drugs Consumption by Top Countries
5.4.1 United States Gene Therapy Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Gene Therapy Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Gene Therapy Drugs Market Analysis
6.1 East Asia Gene Therapy Drugs Consumption and Value Analysis
6.1.1 East Asia Gene Therapy Drugs Market Under COVID-19
6.2 East Asia Gene Therapy Drugs Consumption Volume by Types
6.3 East Asia Gene Therapy Drugs Consumption Structure by Application
6.4 East Asia Gene Therapy Drugs Consumption by Top Countries
6.4.1 China Gene Therapy Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Gene Therapy Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Gene Therapy Drugs Market Analysis
7.1 Europe Gene Therapy Drugs Consumption and Value Analysis
7.1.1 Europe Gene Therapy Drugs Market Under COVID-19
7.2 Europe Gene Therapy Drugs Consumption Volume by Types
7.3 Europe Gene Therapy Drugs Consumption Structure by Application
7.4 Europe Gene Therapy Drugs Consumption by Top Countries
7.4.1 Germany Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.3 France Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Gene Therapy Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Gene Therapy Drugs Market Analysis
8.1 South Asia Gene Therapy Drugs Consumption and Value Analysis
8.1.1 South Asia Gene Therapy Drugs Market Under COVID-19
8.2 South Asia Gene Therapy Drugs Consumption Volume by Types
8.3 South Asia Gene Therapy Drugs Consumption Structure by Application
8.4 South Asia Gene Therapy Drugs Consumption by Top Countries
8.4.1 India Gene Therapy Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Gene Therapy Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Gene Therapy Drugs Market Analysis
9.1 Southeast Asia Gene Therapy Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Gene Therapy Drugs Market Under COVID-19
9.2 Southeast Asia Gene Therapy Drugs Consumption Volume by Types
9.3 Southeast Asia Gene Therapy Drugs Consumption Structure by Application
9.4 Southeast Asia Gene Therapy Drugs Consumption by Top Countries
9.4.1 Indonesia Gene Therapy Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Gene Therapy Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Gene Therapy Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Gene Therapy Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Gene Therapy Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Gene Therapy Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Gene Therapy Drugs Market Analysis
10.1 Middle East Gene Therapy Drugs Consumption and Value Analysis
10.1.1 Middle East Gene Therapy Drugs Market Under COVID-19
10.2 Middle East Gene Therapy Drugs Consumption Volume by Types
10.3 Middle East Gene Therapy Drugs Consumption Structure by Application
10.4 Middle East Gene Therapy Drugs Consumption by Top Countries
10.4.1 Turkey Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Gene Therapy Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Gene Therapy Drugs Market Analysis
11.1 Africa Gene Therapy Drugs Consumption and Value Analysis
11.1.1 Africa Gene Therapy Drugs Market Under COVID-19
11.2 Africa Gene Therapy Drugs Consumption Volume by Types
11.3 Africa Gene Therapy Drugs Consumption Structure by Application
11.4 Africa Gene Therapy Drugs Consumption by Top Countries
11.4.1 Nigeria Gene Therapy Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Gene Therapy Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Gene Therapy Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Gene Therapy Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Gene Therapy Drugs Market Analysis
12.1 Oceania Gene Therapy Drugs Consumption and Value Analysis
12.2 Oceania Gene Therapy Drugs Consumption Volume by Types
12.3 Oceania Gene Therapy Drugs Consumption Structure by Application
12.4 Oceania Gene Therapy Drugs Consumption by Top Countries
12.4.1 Australia Gene Therapy Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Gene Therapy Drugs Market Analysis
13.1 South America Gene Therapy Drugs Consumption and Value Analysis
13.1.1 South America Gene Therapy Drugs Market Under COVID-19
13.2 South America Gene Therapy Drugs Consumption Volume by Types
13.3 South America Gene Therapy Drugs Consumption Structure by Application
13.4 South America Gene Therapy Drugs Consumption Volume by Major Countries
13.4.1 Brazil Gene Therapy Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Gene Therapy Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Gene Therapy Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Gene Therapy Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Gene Therapy Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Gene Therapy Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Gene Therapy Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Gene Therapy Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Gene Therapy Drugs Business
14.1 F. Hoffmann-La Roche AG
14.1.1 F. Hoffmann-La Roche AG Company Profile
14.1.2 F. Hoffmann-La Roche AG Gene Therapy Drugs Product Specification
14.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Bluebird Bio
14.2.1 Bluebird Bio Company Profile
14.2.2 Bluebird Bio Gene Therapy Drugs Product Specification
14.2.3 Bluebird Bio Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Ultragenyx Pharmaceutical?Inc.
14.3.1 Ultragenyx Pharmaceutical?Inc. Company Profile
14.3.2 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Product Specification
14.3.3 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Novartis International AG
14.4.1 Novartis International AG Company Profile
14.4.2 Novartis International AG Gene Therapy Drugs Product Specification
14.4.3 Novartis International AG Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 BioMarin Pharmaceutical
14.5.1 BioMarin Pharmaceutical Company Profile
14.5.2 BioMarin Pharmaceutical Gene Therapy Drugs Product Specification
14.5.3 BioMarin Pharmaceutical Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Gilead Sciences, Inc.
14.6.1 Gilead Sciences, Inc. Company Profile
14.6.2 Gilead Sciences, Inc. Gene Therapy Drugs Product Specification
14.6.3 Gilead Sciences, Inc. Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Sangamo Therapeutics
14.7.1 Sangamo Therapeutics Company Profile
14.7.2 Sangamo Therapeutics Gene Therapy Drugs Product Specification
14.7.3 Sangamo Therapeutics Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Audentes Therapeutics
14.8.1 Audentes Therapeutics Company Profile
14.8.2 Audentes Therapeutics Gene Therapy Drugs Product Specification
14.8.3 Audentes Therapeutics Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Applied Genetic Technologies Corp
14.9.1 Applied Genetic Technologies Corp Company Profile
14.9.2 Applied Genetic Technologies Corp Gene Therapy Drugs Product Specification
14.9.3 Applied Genetic Technologies Corp Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Nightstar Therapeutics
14.10.1 Nightstar Therapeutics Company Profile
14.10.2 Nightstar Therapeutics Gene Therapy Drugs Product Specification
14.10.3 Nightstar Therapeutics Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Spark Therapeutics
14.11.1 Spark Therapeutics Company Profile
14.11.2 Spark Therapeutics Gene Therapy Drugs Product Specification
14.11.3 Spark Therapeutics Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Voyager Therapeutics
14.12.1 Voyager Therapeutics Company Profile
14.12.2 Voyager Therapeutics Gene Therapy Drugs Product Specification
14.12.3 Voyager Therapeutics Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 uniQure
14.13.1 uniQure Company Profile
14.13.2 uniQure Gene Therapy Drugs Product Specification
14.13.3 uniQure Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 VBL Therapeutics
14.14.1 VBL Therapeutics Company Profile
14.14.2 VBL Therapeutics Gene Therapy Drugs Product Specification
14.14.3 VBL Therapeutics Gene Therapy Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Gene Therapy Drugs Market Forecast (2022-2027)
15.1 Global Gene Therapy Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Gene Therapy Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Gene Therapy Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Gene Therapy Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Gene Therapy Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Gene Therapy Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Gene Therapy Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Gene Therapy Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Gene Therapy Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Gene Therapy Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Gene Therapy Drugs Price Forecast by Type (2022-2027)
15.4 Global Gene Therapy Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Gene Therapy Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
